Contact
Please use this form to send email to PR contact of this press release:
Immunomic Therapeutics Completes Enrollment for Phase I of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar Allergy
TO:
Please use this form to send email to PR contact of this press release:
Immunomic Therapeutics Completes Enrollment for Phase I of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar Allergy
TO: